Literature DB >> 15851327

The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis.

Amit S Dhamoon1, José Jalife.   

Abstract

The cardiac inwardly rectifying potassium current (I(K1)) stabilizes the resting membrane potential and is responsible for shaping the initial depolarization and final repolarization of the action potential. The inwardly rectifying potassium channel (Kir2.x) subfamily members primarily mediate cardiac I(K1), but other inward rectifiers, including the acetylcholine-sensitive (Kir3.x) and ATP-sensitive (Kir6.x) inward rectifiers, also may modulate cardiac excitability. Studies suggest I(K1) plays a role in ventricular arrhythmias, highlighted by the recently described Andersen's syndrome and studies in the guinea pig heart model of ventricular fibrillation. This article describes the salient properties of cardiac I(K1) and discusses the role of this current in the cardiac action potential and in underlying regional differences in cardiac excitability. The mechanism of channel block, assembly, and structure are reviewed. The article discusses the role of I(K1) in ventricular fibrillation and speculates on modulation of I(K1) as a preventative antiarrhythmic mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851327     DOI: 10.1016/j.hrthm.2004.11.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  90 in total

1.  Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97.

Authors:  Ravi Vaidyanathan; Steven M Taffet; Karen L Vikstrom; Justus M B Anumonwo
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Aging and atrial fibrillation research: where we are and where we should go.

Authors:  Sandeep V Pandit; José Jalife
Journal:  Heart Rhythm       Date:  2006-11-17       Impact factor: 6.343

3.  Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells.

Authors:  Teun P de Boer; Toon A B van Veen; Marien J C Houtman; John A Jansen; Shirley C M van Amersfoorth; Pieter A Doevendans; Marc A Vos; Marcel A G van der Heyden
Journal:  Med Biol Eng Comput       Date:  2006-04-20       Impact factor: 2.602

4.  Differential polyamine sensitivity in inwardly rectifying Kir2 potassium channels.

Authors:  Brian K Panama; Anatoli N Lopatin
Journal:  J Physiol       Date:  2005-12-22       Impact factor: 5.182

5.  Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.

Authors:  Tong Lu; Dan Ye; Xiaoli Wang; John M Seubert; Joan P Graves; J Alyce Bradbury; Darryl C Zeldin; Hon-Chi Lee
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

6.  Generation and escape of local waves from the boundary of uncoupled cardiac tissue.

Authors:  Vadim N Biktashev; Ara Arutunyan; Narine A Sarvazyan
Journal:  Biophys J       Date:  2008-01-22       Impact factor: 4.033

Review 7.  Pathophysiology of ventricular tachyarrhythmias : From automaticity to reentry.

Authors:  Andres Enriquez; David S Frankel; Adrian Baranchuk
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-31

8.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

9.  Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil.

Authors:  Fangfang Ma; Hiroki Takanari; Kimiko Masuda; Masaki Morishima; Katsushige Ono
Journal:  Heart Vessels       Date:  2015-10-26       Impact factor: 2.037

10.  KirBac1.1: it's an inward rectifying potassium channel.

Authors:  Wayland W L Cheng; Decha Enkvetchakul; Colin G Nichols
Journal:  J Gen Physiol       Date:  2009-02-09       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.